Thanks to Shroomer for placing SSDP’s work to stand against the scheduling of DOI & DOC.
“DOI and DOC are two crucial medical tools that have been used safely in laboratories for decades. Together, they have featured in more than 900 research articles and show promise for pain management, combatting anxiety and depression, preventing overdose, and treating substance abuse disorder,” Kat Murti, SSDP’s Executive Director emphasized. “The future of psychedelics rests in our hands,” she continued, urging support for SSDP’s ongoing legal fight to prevent the scheduling of these compounds.